To include your compound in the COVID-19 Resource Center, submit it here.

CTP-730: Phase I started

Concert began a double-blind, placebo-controlled, Australian Phase I trial to evaluate single doses of 5, 10, 20, 30 and 40

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE